5-aminolevulinic acid guidance during awake craniotomy to maximise extent of safe resection of glioblastoma multiforme

BMJ Case Reports

Volumn 2015, Issue , 2015, Pages

  Corns, Robert ^a   Mukherjee, Soumya ^a   Johansen, Anja ^a   Sivakumar, Gnanamurthy ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; CARMUSTINE; DEXAMETHASONE;

ADULT; ARTICLE; AWAKE CRANIOTOMY; BRAIN DAMAGE; CANCER SURGERY; CANCER TISSUE; CASE REPORT; CHEMORADIOTHERAPY; CRANIOTOMY; CYTOREDUCTIVE SURGERY; DIAGONAL BAND OF BROCA; FEMALE; FLUORESCENCE; FRONTAL LOBE; GLIOBLASTOMA; HEADACHE; HUMAN; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURGICAL MICROSCOPE; SURGICAL TECHNIQUE; TUMOR RECURRENCE; BRAIN; BRAIN NEOPLASMS; NEUROSURGERY; PATHOLOGY; PROCEDURES;

ADULT; AMINOLEVULINIC ACID; BRAIN; BRAIN NEOPLASMS; CRANIOTOMY; FEMALE; FLUORESCENCE; GLIOBLASTOMA; HUMANS; NEUROSURGICAL PROCEDURES;

EID: 84938941114     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2014-208575     Document Type: Article

References (2)

1. Liang D, Schulder M. The role of intraoperative magnetic resonance imaging in glioma surgery. Surg Neurol Int 2012;3:S320-7.
2. Stummer W, Pichlmeier U, Meinel T, et al., ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomized controlled multicentre phase III trial. Lancet Oncol 2006;7:392-401.